Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,088 | -2,153 | -1,572 | 243 | -7,371 |
| Depreciation Amortization | 212 | 159 | 106 | 53 | 536 |
| Accounts receivable | -302 | -119 | -185 | -224 | 12 |
| Other Working Capital | -1,166 | -522 | -293 | -190 | -478 |
| Other Operating Activity | 529 | 60 | 493 | -799 | 4,806 |
| Operating Cash Flow | $-3,815 | $-2,575 | $-1,451 | $-917 | $-2,495 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-13 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 1,572 |
| Debt Repayment | N/A | N/A | N/A | N/A | -3,250 |
| Common Stock Issued | 3,791 | 3,102 | 1,206 | 1 | 4,881 |
| Financing Cash Flow | $3,791 | $3,102 | $1,206 | $1 | $3,203 |
| Exchange Rate Effect | 1 | 2 | -2 | -1 | -3 |
| Beginning Cash Position | 1,284 | 1,284 | 1,284 | 1,284 | 579 |
| End Cash Position | 1,248 | 1,813 | 1,037 | 367 | 1,284 |
| Net Cash Flow | $-36 | $529 | $-247 | $-917 | $705 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,815 | -2,575 | -1,451 | -917 | -2,495 |
| Capital Expenditure | -13 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -3,828 | -2,575 | -1,451 | -917 | -2,495 |